ILMN Illumina Inc Return on Gross Profit

Official company branding of Illumina Platform (ILMN)

Illumina, Inc. (ILMN) earns revenue from the sale of unique DNA sequencers, yet its primary income is generated via a "razor-and-blade" model through the supply of consumables. The gross profit-to-revenue ratio demonstrates the efficiency of this mechanism, with the indicator currently standing at 68.30. Jacob Thaysen's team is now striving to stabilize key operations and restore shareholder confidence following a period of corporate disputes.

ILMN Illumina Inc Gross Profitability (07/04/2022 - 11/20/2026)

Comprehensive metric breakdowns and analytics for Illumina, Inc. (ILMN)

- market value and analyst target forecast:
Fundamental valuation:ILMN - Illumina Inc
Manufactured product of Illumina Platform

Gross margin is calculated as the portion of revenue minus direct production costs, determining the efficiency of the core operating cycle. This indicator demonstrates the business's fundamental margin of safety, excluding the impact of tax adjustments and GAAP accounting manipulations. For Illumina, Inc. (ILMN), this metric depends directly on the cost of component outsourcing and cloud infrastructure. The gross margin trend allows for an assessment of the real profitability of DNA analysis technologies.